IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated patholog...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WENGLOWSKY, STEVEN, M FENG, BAINIAN REN, LI MALESKY, KIM HANSEN, JOSHUA, D RUDOLPH, JOACHIM GRINA, JONAS AHRENDT, KATERI, A YOUNG, WENDY, B LAIRD, ELLEN, R MATHIEU, SIMON WEN, ZHAOYANG NEWHOUSE, BRAD MORENO, DAVID, A BUCKMELTER, ALEXANDRE, J |
| description | Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2265609A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2265609A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2265609A13</originalsourceid><addsrcrecordid>eNrjZLD29HXxjPJXiDbRUzDVdYpVCIgM8nTx9HNVcHEN8gxzDPEMcw1WCA12dVFwDFYIcnRT8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUZGZqZmBpaOhsZEKAEAX7gokw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS</title><source>esp@cenet</source><creator>WENGLOWSKY, STEVEN, M ; FENG, BAINIAN ; REN, LI ; MALESKY, KIM ; HANSEN, JOSHUA, D ; RUDOLPH, JOACHIM ; GRINA, JONAS ; AHRENDT, KATERI, A ; YOUNG, WENDY, B ; LAIRD, ELLEN, R ; MATHIEU, SIMON ; WEN, ZHAOYANG ; NEWHOUSE, BRAD ; MORENO, DAVID, A ; BUCKMELTER, ALEXANDRE, J</creator><creatorcontrib>WENGLOWSKY, STEVEN, M ; FENG, BAINIAN ; REN, LI ; MALESKY, KIM ; HANSEN, JOSHUA, D ; RUDOLPH, JOACHIM ; GRINA, JONAS ; AHRENDT, KATERI, A ; YOUNG, WENDY, B ; LAIRD, ELLEN, R ; MATHIEU, SIMON ; WEN, ZHAOYANG ; NEWHOUSE, BRAD ; MORENO, DAVID, A ; BUCKMELTER, ALEXANDRE, J</creatorcontrib><description>Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.</description><language>eng ; fre ; ger</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101229&DB=EPODOC&CC=EP&NR=2265609A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101229&DB=EPODOC&CC=EP&NR=2265609A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WENGLOWSKY, STEVEN, M</creatorcontrib><creatorcontrib>FENG, BAINIAN</creatorcontrib><creatorcontrib>REN, LI</creatorcontrib><creatorcontrib>MALESKY, KIM</creatorcontrib><creatorcontrib>HANSEN, JOSHUA, D</creatorcontrib><creatorcontrib>RUDOLPH, JOACHIM</creatorcontrib><creatorcontrib>GRINA, JONAS</creatorcontrib><creatorcontrib>AHRENDT, KATERI, A</creatorcontrib><creatorcontrib>YOUNG, WENDY, B</creatorcontrib><creatorcontrib>LAIRD, ELLEN, R</creatorcontrib><creatorcontrib>MATHIEU, SIMON</creatorcontrib><creatorcontrib>WEN, ZHAOYANG</creatorcontrib><creatorcontrib>NEWHOUSE, BRAD</creatorcontrib><creatorcontrib>MORENO, DAVID, A</creatorcontrib><creatorcontrib>BUCKMELTER, ALEXANDRE, J</creatorcontrib><title>IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS</title><description>Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD29HXxjPJXiDbRUzDVdYpVCIgM8nTx9HNVcHEN8gxzDPEMcw1WCA12dVFwDFYIcnRT8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUZGZqZmBpaOhsZEKAEAX7gokw</recordid><startdate>20101229</startdate><enddate>20101229</enddate><creator>WENGLOWSKY, STEVEN, M</creator><creator>FENG, BAINIAN</creator><creator>REN, LI</creator><creator>MALESKY, KIM</creator><creator>HANSEN, JOSHUA, D</creator><creator>RUDOLPH, JOACHIM</creator><creator>GRINA, JONAS</creator><creator>AHRENDT, KATERI, A</creator><creator>YOUNG, WENDY, B</creator><creator>LAIRD, ELLEN, R</creator><creator>MATHIEU, SIMON</creator><creator>WEN, ZHAOYANG</creator><creator>NEWHOUSE, BRAD</creator><creator>MORENO, DAVID, A</creator><creator>BUCKMELTER, ALEXANDRE, J</creator><scope>EVB</scope></search><sort><creationdate>20101229</creationdate><title>IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS</title><author>WENGLOWSKY, STEVEN, M ; FENG, BAINIAN ; REN, LI ; MALESKY, KIM ; HANSEN, JOSHUA, D ; RUDOLPH, JOACHIM ; GRINA, JONAS ; AHRENDT, KATERI, A ; YOUNG, WENDY, B ; LAIRD, ELLEN, R ; MATHIEU, SIMON ; WEN, ZHAOYANG ; NEWHOUSE, BRAD ; MORENO, DAVID, A ; BUCKMELTER, ALEXANDRE, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2265609A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2010</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WENGLOWSKY, STEVEN, M</creatorcontrib><creatorcontrib>FENG, BAINIAN</creatorcontrib><creatorcontrib>REN, LI</creatorcontrib><creatorcontrib>MALESKY, KIM</creatorcontrib><creatorcontrib>HANSEN, JOSHUA, D</creatorcontrib><creatorcontrib>RUDOLPH, JOACHIM</creatorcontrib><creatorcontrib>GRINA, JONAS</creatorcontrib><creatorcontrib>AHRENDT, KATERI, A</creatorcontrib><creatorcontrib>YOUNG, WENDY, B</creatorcontrib><creatorcontrib>LAIRD, ELLEN, R</creatorcontrib><creatorcontrib>MATHIEU, SIMON</creatorcontrib><creatorcontrib>WEN, ZHAOYANG</creatorcontrib><creatorcontrib>NEWHOUSE, BRAD</creatorcontrib><creatorcontrib>MORENO, DAVID, A</creatorcontrib><creatorcontrib>BUCKMELTER, ALEXANDRE, J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WENGLOWSKY, STEVEN, M</au><au>FENG, BAINIAN</au><au>REN, LI</au><au>MALESKY, KIM</au><au>HANSEN, JOSHUA, D</au><au>RUDOLPH, JOACHIM</au><au>GRINA, JONAS</au><au>AHRENDT, KATERI, A</au><au>YOUNG, WENDY, B</au><au>LAIRD, ELLEN, R</au><au>MATHIEU, SIMON</au><au>WEN, ZHAOYANG</au><au>NEWHOUSE, BRAD</au><au>MORENO, DAVID, A</au><au>BUCKMELTER, ALEXANDRE, J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS</title><date>2010-12-29</date><risdate>2010</risdate><abstract>Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP2265609A1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | IMDIZO [4. 5-B] PYRIDINE DERIVATIVES USED AS RAF INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A50%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WENGLOWSKY,%20STEVEN,%20M&rft.date=2010-12-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2265609A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |